These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9287181)

  • 1. HIV. A clever hijacker of the immune system.
    Bolognesi DP
    Curr Opin Immunol; 1997 Aug; 9(4):549-50. PubMed ID: 9287181
    [No Abstract]   [Full Text] [Related]  

  • 2. Co-receptors for HIV-1 entry.
    Moore JP; Trkola A; Dragic T
    Curr Opin Immunol; 1997 Aug; 9(4):551-62. PubMed ID: 9287172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [HIV-1 virus uses a double-key mechanism to infect the cell].
    Uccini S
    Pathologica; 1997 Apr; 89(2):199-200. PubMed ID: 9411374
    [No Abstract]   [Full Text] [Related]  

  • 4. Partial inactivation of CCR5- and CXCR4- tropic HIV-1 by human urine.
    Auvert B; Jenabian MA; Saidi H; Lissouba P; Bélec L
    Arch Virol; 2011 Dec; 156(12):2181-6. PubMed ID: 21947506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The plasma membrane as a combat zone in the HIV battlefield.
    Doms RW; Trono D
    Genes Dev; 2000 Nov; 14(21):2677-88. PubMed ID: 11069884
    [No Abstract]   [Full Text] [Related]  

  • 6. CD4-Dependent and CD4-independent utilization of coreceptors by human immunodeficiency viruses type 2 and simian immunodeficiency viruses.
    Liu HY; Soda Y; Shimizu N; Haraguchi Y; Jinno A; Takeuchi Y; Hoshino H
    Virology; 2000 Dec; 278(1):276-88. PubMed ID: 11112502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of highly active antiretroviral treatment on expression of HIV-1 coreceptors and ligand levels in peripheral blood from HIV-1 infected patients in China.
    Fang J; Bai S; Wu L; Zhu X; Yao X; Jin C; Wang C
    J Int Med Res; 2013 Oct; 41(5):1560-9. PubMed ID: 24043708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: a comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac.
    Chen Z; Gettie A; Ho DD; Marx PA
    Virology; 1998 Jun; 246(1):113-24. PubMed ID: 9656999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Inhibition of HIV-1 Entry Imposed by Interferon Inducible Transmembrane Proteins Is Independent of Co-Receptor Usage.
    Yu J; Liu SL
    Viruses; 2018 Aug; 10(8):. PubMed ID: 30087232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of dendritic cells in the infection of CD4+ T cells with the human immunodeficiency virus: use of dendritic cells from individuals homozygous for the delta32CCR5 allele as a model.
    Dybul M; Weissman D; Rubbert A; Machado E; Cohn M; Ehler L; O'Callahan M; Mizell S; Fauci AS
    AIDS Res Hum Retroviruses; 1998 Sep; 14(13):1109-13. PubMed ID: 9737582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-Dendritic cell interactions promote efficient viral infection of T cells.
    Zoeteweij JP; Blauvelt A
    J Biomed Sci; 1998; 5(4):253-9. PubMed ID: 9691217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How do viruses enter cells? The HIV coreceptors teach us a lesson of complexity.
    Dimitrov DS
    Cell; 1997 Dec; 91(6):721-30. PubMed ID: 9413981
    [No Abstract]   [Full Text] [Related]  

  • 13. Dendritic cells express and use multiple HIV coreceptors.
    Weissman D; Rubbert A; Combadiere C; Murphy PM; Fauci AS
    Adv Exp Med Biol; 1997; 417():401-6. PubMed ID: 9286393
    [No Abstract]   [Full Text] [Related]  

  • 14. V3 loop-determined coreceptor preference dictates the dynamics of CD4+-T-cell loss in simian-human immunodeficiency virus-infected macaques.
    Ho SH; Shek L; Gettie A; Blanchard J; Cheng-Mayer C
    J Virol; 2005 Oct; 79(19):12296-303. PubMed ID: 16160156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent in vitro inactivation of both free and cell-associated CCR5- and CXCR4-tropic HIV-1 by common commercial soap bars from South Africa.
    Jenabian MA; Auvert B; Saïdi H; Lissouba P; Matta M; Bélec L
    J Acquir Immune Defic Syndr; 2010 Aug; 54(4):340-2. PubMed ID: 20517160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Giving HIV a dose of its own medicine.
    Bonetta L
    Nat Med; 1998 Jan; 4(1):17. PubMed ID: 9427597
    [No Abstract]   [Full Text] [Related]  

  • 17. HIV-1 entry inhibitors: evading the issue.
    Michael NL; Moore JP
    Nat Med; 1999 Jul; 5(7):740-2. PubMed ID: 10395316
    [No Abstract]   [Full Text] [Related]  

  • 18. Simultaneous Knockout of CXCR4 and CCR5 Genes in CD4+ T Cells via CRISPR/Cas9 Confers Resistance to Both X4- and R5-Tropic Human Immunodeficiency Virus Type 1 Infection.
    Yu S; Yao Y; Xiao H; Li J; Liu Q; Yang Y; Adah D; Lu J; Zhao S; Qin L; Chen X
    Hum Gene Ther; 2018 Jan; 29(1):51-67. PubMed ID: 28599597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV type 1-infected dendritic cells induce apoptotic death in infected and uninfected primary CD4 T lymphocytes.
    Lichtner M; Marañón C; Vidalain PO; Azocar O; Hanau D; Lebon P; Burgard M; Rouzioux C; Vullo V; Yagita H; Rabourdin-Combe C; Servet C; Hosmalin A
    AIDS Res Hum Retroviruses; 2004 Feb; 20(2):175-82. PubMed ID: 15018705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The emerging race to cure HIV infections.
    Cohen J
    Science; 2011 May; 332(6031):784-5, 787-9. PubMed ID: 21566173
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.